SOLID-STATE STRUCTURES AND CONFORMATIONAL STUDIES OF 4 1,2,3,4-TETRAHYDROACRIDINE ALZHEIMERS-DISEASE THERAPEUTICS

被引:13
作者
BANDOLI, G
DOLMELLA, A
GATTO, S
NICOLINI, M
机构
[1] Department of Pharmaceutical Sciences, via Marzolo 5, Padua
关键词
D O I
10.1007/BF01670205
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The solid-state structures of four 1,2,3,4-tetrahydroacridines [tacrine hydrochloride monohydrate (1), 7-methoxytacrine hydrochloride monohydrate (2), velnacrine hydrogenmaleate (3) and suronacrine hydrogenmaleate (4)] were determined from single-crystal X-ray diffraction analysis. (1): monoclinic, P2(1)/n, a = 8.778(1), b = 8.521(1), c = 17.603(2) angstrom, beta = 101.34(1)-degrees. (2): monoclinic, C2/c, a = 12.326(7), b = 18.050(9), c = 13.822(8) angstrom, beta = 113.70(4)-degrees. (3): triclinic, P1BAR, a = 7.349(2), b = 9.417(3), c = 12.557(4) angstrom, alpha = 109.62(2), beta = 98.12(2), gamma = 101.18(2)-degrees. (4): monoclinic, P2(1)/n, a = 8.513(6), b = 18.74(1), c = 13.401(6) angstrom, beta = 91.21(5)-degrees. Final R factors for compounds (1)-(4) are 0.047, 0.057, 0.057, 0.11, respectively. The overall arrangement of the common aminotetrahydroacridine skeleton looks similar in all derivatives. However, whereas enantiomerization of the unsubstituted cyclohexenyl rings occurs in (1) and (2), only quasi-axially hydroxyl substituted diastereomers are found for (3) and (4). This is presumably due to the different propensities for hydrogen bonding of axially vs. equatorially disposed hydroxyl groups with the hydrogenmaleate anions. Empirical and semiempirical calculations were performed to examine the conformational behavior of the four compounds, both in vacuo and in solution.
引用
收藏
页码:301 / 310
页数:10
相关论文
共 43 条
  • [1] THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION
    BARTUS, RT
    DEAN, RL
    BEER, B
    LIPPA, AS
    [J]. SCIENCE, 1982, 217 (4558) : 408 - 417
  • [2] MECHANISMS OF CHOLINESTERASE INHIBITION IN SENILE DEMENTIA OF THE ALZHEIMER TYPE - CLINICAL, PHARMACOLOGICAL, AND THERAPEUTIC ASPECTS
    BECKER, RE
    GIACOBINI, E
    [J]. DRUG DEVELOPMENT RESEARCH, 1988, 12 (3-4) : 163 - 195
  • [3] BECKER RE, 1991, CHOLINERGIC BASIS AL
  • [4] BECKER RE, 1989, ALZHEIMERS DISEASE R, P1121
  • [5] EFFECTS OF TACRINE, VELNACRINE (HP029), SURONACRINE (HP128), AND 3,4-DIAMINOPYRIDINE ON SKELETAL NEUROMUSCULAR-TRANSMISSION INVITRO
    BRAGA, MFM
    HARVEY, AL
    ROWAN, EG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (04) : 909 - 915
  • [6] STRUCTURE OF 1,1-BIS(BROMOMETHYL)-1,2,3,4-TETRAHYDROACRIDINE
    BUKOWSKASTRZYZEWSKA, M
    SKOWERANDA, J
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1980, 36 (APR): : 886 - 889
  • [7] BUKOWSKASTRZYZEWSKA M, 1979, ACTA CRYSTALLOGR B, V35, P633, DOI 10.1107/S0567740879004325
  • [8] CRYSTAL-STRUCTURE OF AN ANALGETIC METABOLITE, NORPORPOXYPHENE MALEATE
    BYE, E
    [J]. ACTA CHEMICA SCANDINAVICA SERIES B-ORGANIC CHEMISTRY AND BIOCHEMISTRY, 1977, 31 (02): : 157 - 161
  • [9] MOLECULAR STRUCTURE OF CYCLOHEXENE
    CHIANG, JF
    BAUER, SH
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1969, 91 (08) : 1898 - &
  • [10] COURSEILLE C, 1980, CRYST STRUCT COMMUN, V9, P287